Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Triple-negative breast cancer constitutes approximately 12%-17% of all breast cancer cases, and >33% of patients develop distant metastases. Systemic cytotoxic chemotherapy is the primary treatment for patients with metastatic triple-negative breast cancer; however, the role of first-...

全面介紹

Na minha lista:
書目詳細資料
發表在:Technol Cancer Res Treat
Main Authors: Lu, Fei, Hou, Yu, Chen, Zhengting, Jiang, Jie, He, Xi, Xia, Yaoxiong, Cao, Ke, Chang, Li, Li, Wenhui
格式: Artigo
語言:Inglês
出版: SAGE Publications 2021
主題:
Meta-Analysis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120541/
https://ncbi.nlm.nih.gov/pubmed/33977814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/15330338211016369
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍